Raphael Pharmaceutical (RAPH) Share-based Compensation (2022 - 2025)

Raphael Pharmaceutical has disclosed Share-based Compensation across 3 years of filings, most recently posting $1000.0 for Q4 2025.

• Share-based Compensation for Q4 2025 came in at $1000.0, up 104.76% year-over-year; the trailing twelve-month figure through Dec 2025 was $245000.0 (down 87.62% YoY), and the FY2025 annual result was $245000.0, up 512.5% from the prior year.
• Share-based Compensation came in at $1000.0 for Q4 2025 at Raphael Pharmaceutical, down from $39000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $1.2 million in Q3 2022 to a low of -$21000.0 in Q4 2024.
• The 3-year median for Share-based Compensation is $39000.0 (2025), against an average of $317714.3.
• Peak annual rise in Share-based Compensation reached 104.76% in 2025, while the deepest fall reached 104.76% in 2025.
• Raphael Pharmaceutical's Share-based Compensation stood at $800000.0 in 2022, then slumped by 102.63% to -$21000.0 in 2024, then soared by 104.76% to $1000.0 in 2025.
• The last three Share-based Compensation figures came in at $1000.0 (Q4 2025), $39000.0 (Q3 2025), and $8000.0 (Q2 2025), per Business Quant data.